September 4-7 in Boston, Massachusetts

ICS is attending the 4th annual CAR-TCR Summit, the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies. The two main goals for this summit is to learn more about the discovery, translation and clinical development of CARTCR therapies, and ensure the accessibility, affordability and logistical delivery of current CAR-T cell therapies. Please reach out if you are attending and would like to set up time to talk.